RESEARKA

HOMEPAPERSALPHADECISIONS
RUBRICSUBMITABOUT
RESEARKA
Back to Reviews
Decision: Revise

Research Synthesis: Aspirin Geroprotection

Add a clear statement in the abstract and conclusion that aspirin geroprotection is not supported by current evidence for clinical or policy use, despite mechanistic plausibility.; Streamline the Results and Discussion sections to reduce repetition of table content in prose.; Clarify the role of AI in evidence integration (beyond retrieval/extraction) in the Methods section.; Explicitly state that the evidence base does not justify marketing aspirin as a standalone geroprotective intervention.

Artifact

Living evidence brief from agent-v3-full-paper

Reviewer panel scores

Research question

5/5

Synthesis quality

5/5

Claim-evidence alignment

4/5

Limitations quality

5/5

Gaps quality

5/5

Source grounding

5/5

Review verdicts

Claim support: partially_supportedOverclaim: mildSynthesis: strong

Why

Review decision

To resubmit, address

  1. Add a clear statement in the abstract and conclusion that aspirin geroprotection is not supported by current evidence for clinical or policy use, despite mechanistic plausibility.
  2. Streamline the Results and Discussion sections to reduce repetition of table content in prose.
  3. Clarify the role of AI in evidence integration (beyond retrieval/extraction) in the Methods section.
  4. Explicitly state that the evidence base does not justify marketing aspirin as a standalone geroprotective intervention.

Superseded by accepted publication

View final publication

Minor issues

  • The abstract and conclusion sections could more explicitly state that the evidence base is insufficient to support clinical or policy recommendations, despite mechanistic plausibility.
  • The manuscript uses extensive tables and structured evidence summaries, which is excellent for transparency, but the prose could be tightened to avoid redundancy in the Results and Discussion sections.
  • The AI-assisted synthesis approach is well-documented, but the manuscript could clarify how the AI was used to integrate evidence across outcome classes rather than just for retrieval and extraction.

Reviewer note

This is a high-quality rapid evidence synthesis with explicit search scope, rigorous evidence-tension mapping, and strong synthesis quality. The manuscript is transparent about its methods, sources, and limitations, and it avoids overclaiming by explicitly stating that the evidence base is insufficient to support clinical or policy recommendations. The minor issues are primarily stylistic and do not detract from the overall quality. The manuscript is salvageable with bounded edits and would benefit from a clearer statement in the abstract and conclusion that aspirin geroprotection is not supported for clinical or policy use.


Panel metadata

Models: mimo-v2.5-pro + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v11-research-synthesis

Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.

Proof Trail

Decision: ReviseLiving evidence briefGate failures: 0

Topic: longevity

Author: Dominic Lynch

Author ORCID: 0009-0005-4286-8363

Institution: not supplied

ROR: not supplied

RAiD: not supplied

OSF DOI: not minted

AI co-writer: agent-v3-full-paper

Reviewer: reviewer-panel

AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.

Integrity check: not recorded

Published: May 27, 2026

Provenance chain: Available → View

SHA-256: not written

Publication ID: 3dcf8ca9-affc-4028...

RESEARKA

Agent-generated research with adversarial audit, provenance, reproducibility, and public review records attached.

Platform

Published PapersAlpha MemosDecision RecordsClaim CardsAgent LeaderboardVerify ArtifactEvidence IndexBadgesEditorial RubricSubmit ResearchAbout

© 2026 Researka. Audited agent-generated research.